Get started
Author

Vanja Vaccaro

PTEN: Multiple Functions in Human Malignant Tumors
2015 · Michele Milella, Italia Falcone, et al. · Frontiers in Oncology · 484
PDF
Differential Activity of Nivolumab, Pembrolizumab and MPDL3280A according to the Tumor Expression of Programmed Death-Ligand-1 (PD-L1): Sensitivity Analysis of Trials in Melanoma, Lung and Genitourinary Cancers
2015 · Luisa Carbognin, Sara Pilotto, et al. · PLoS ONE · 457
PDF
PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting
2014 · Ludovica Ciuffreda, Italia Falcone, et al. · Advances in Biological Regulation · 85
Metastatic pancreatic cancer: Is there a light at the end of the tunnel?
2015 · Vanja Vaccaro · World Journal of Gastroenterology · 63
PDF
Morphologic and Molecular Landscape of Pancreatic Cancer Variants as the Basis of New Therapeutic Strategies for Precision Oncology
2020 · Chiara Bazzichetto, Claudio Luchini, et al. · International Journal of Molecular Sciences · 58
PDF
Magnitude of benefit of the addition of bevacizumab to first-line chemotherapy for metastatic colorectal cancer: meta-analysis of randomized clinical trials
2010 · Fotios Loupakis, Emilio Bria, et al. · Journal of Experimental & Clinical Cancer Research · 56
PDF
Emerging pathways and future targets for the molecular therapy of pancreatic cancer
2011 · Vanja Vaccaro, Davide Melisi, et al. · Expert Opinion on Therapeutic Targets · 55
Influenza Vaccine Indication During Therapy with Immune Checkpoint Inhibitors: A Transversal Challenge. The Invidia Study
2018 · Melissa Bersanelli, Diana Giannarelli, et al. · Immunotherapy · 46
PDF
Clinical impact of anti‐epidermal growth factor receptor monoclonal antibodies in first‐line treatment of metastatic colorectal cancer
2011 · Fotios Loupakis, Chiara Cremolini, et al. · Cancer · 40
Efficacy and Safety of Lanreotide Autogel and Temozolomide Combination Therapy in Progressive Thoracic Neuroendocrine Tumors (Carcinoid): Results from the Phase 2 ATLANT Study
2022 · Piero Ferolla, Alfredo Berruti, et al. · Neuroendocrinology · 36
Trastuzumab cardiotoxicity: biological hypotheses and clinical open issues
2008 · Emilio Bria, Federica Cuppone, et al. · Expert Opinion on Biological Therapy · 36
From Genetic Alterations to Tumor Microenvironment: The Ariadne’s String in Pancreatic Cancer
2020 · Chiara Bazzichetto, Fabiana Conciatori, et al. · Cells · 33
PDF
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
2011 · Federica Cuppone, Emilio Bria, et al. · Journal of Experimental & Clinical Cancer Research · 31
PDF
Prognostic factors in gemcitabine–cisplatin polychemotherapy regimens in pancreatic cancer: XPD‐Lys751Gln polymorphism strikes back
2013 · Amir Avan, Paola Pacetti, et al. · International Journal of Cancer · 28
Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG
2020 · Melissa Bersanelli, Diana Giannarelli, et al. · Therapeutic Advances in Medical Oncology · 25
Molecular and Genetic Bases of Pancreatic Cancer
2012 · Vanja Vaccaro, Alain Gelibter, et al. · Current Drug Targets · 25
PDF
Impact of Influenza Syndrome and Flu Vaccine on Survival of Cancer Patients During Immunotherapy in the INVIDIa Study
2020 · Melissa Bersanelli, Sebastiano Buti, et al. · Immunotherapy · 23
Impact of hormonal treatment duration in combination with radiotherapy for locally advanced prostate cancer: Meta-analysis of randomized trials
2010 · Federica Cuppone, Emilio Bria, et al. · BMC Cancer · 23
PDF
The role of nanoliposomal irinotecan plus fluorouracil/leucovorin in the continuum of care of patients with metastatic pancreatic ductal adenocarcinoma
2023 · Letizia Procaccio, Valeria Merz, et al. · Cancer Medicine · 17
PDF
Nab-paclitaxel (Nab-P) and gemcitabine (G) as first-line chemotherapy (CT) in advanced pancreatic cancer (APDAC) elderly patients (pts): A “real-life” study.
2015 · Guido Giordano, Vanja Vaccaro, et al. · Journal of Clinical Oncology · 17
First-line erlotinib and fixed dose-rate gemcitabine for advanced pancreatic cancer
2013 · Vanja Vaccaro · World Journal of Gastroenterology · 16
PDF
Management of metastatic renal cell carcinoma patients with poor-risk features: current status and future perspectives
2013 · Matteo Santoni, Michele De Tursi, et al. · Expert Review of Anticancer Therapy · 15
Prognostic analysis and outcomes of metastatic pancreatic cancer patients receiving nab ‐paclitaxel plus gemcitabine as second or later‐line treatment
2024 · Guido Giordano, Michele Milella, et al. · Cancer Medicine · 10
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey
2023 · M. Reni, E. Giommoni, et al. · ESMO Open · 10
PDF
Activity and Safety of NAB-FOLFIRI and NAB-FOLFOX as First-Line Treatment for metastatic Pancreatic Cancer (NabucCO Study)
2021 · Elisa Giommoni, Evaristo Maiello, et al. · Current Oncology · 10
PDF
Works count: 47
Citation count: 1,750
H-index: 18
I10-index: 27
Year
Topic
Type